相关实验视频
Updated: Jan 8, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
在异常性肺纤维化症中改变了新陈代谢
Neal I Callaghan1,2, Locke Davenport Huyer2,3,4,5
1Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
异形性肺纤维化 (IPF) 涉及代谢障碍影响细胞功能. 针对这些代谢途径为这种无法治愈的肺部疾病提供了一个有希望的治疗策略.
科学领域:
- 肺部医学 肺部医学
- 代谢学 代谢学 代谢学
- 细胞生物学 细胞生物学
背景情况:
- 异形性肺纤维化 (IPF) 是一种致命的肺病,死亡率高,治疗选择有限.
- IPF涉及复杂的病因,细胞功能障碍,氧化应激和表面活性剂生产受损.
- 在IPF病原发生过程中,越来越多地发现了明显的代谢障碍.
研究的目的:
- 审查与细胞特异性代谢变化相关的IPF发育机制.
- 为了比较体内和体外IPF模型关于代谢分析.
- 讨论IPF的代谢生物标志物和治疗向策略.
主要方法:
- 文献综述侧重于IPF机制和代谢变化.
- 对各种IPF模型 (体内,体外) 和患者数据的比较分析.
- 识别和讨论代谢相关的生物标志物.
主要成果:
- 在IPF中显而易见的是代谢障碍,影响细胞功能和疾病进展.
- 目前的IPF模型显示,与患者数据相比,代谢概况的变化.
- 代谢是IPF的关键,但在很大程度上尚未开发的治疗点.
结论:
- 了解细胞特异性代谢变化是解开IPF病原学的关键.
- 需要改进体外建模来开发疾病修饰疗法.
- 准失调的新陈代谢有可能成为新的IPF治疗方法.
更多相关视频
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023
03:38Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
Published on: June 20, 2025
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: